As of 2024-10-13, the Relative Valuation of Veracyte Inc (VCYT) is (25.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 34.02 USD, the upside of Veracyte Inc based on Relative Valuation is -174.7%.
The range of the Relative Valuation is (26.12) - (21.56) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 37.1x - 49.3x | 44.6x |
| Forward P/E multiples | 25.4x - 30.6x | 27.6x |
| Fair Price | (26.12) - (21.56) | (25.40) |
| Upside | -176.8% - -163.4% | -174.7% |
| Date | P/E |
| 2024-10-11 | -48.35 |
| 2024-10-10 | -45.86 |
| 2024-10-09 | -45.37 |
| 2024-10-08 | -47.58 |
| 2024-10-07 | -48.14 |
| 2024-10-04 | -46.67 |
| 2024-10-03 | -46.86 |
| 2024-10-02 | -48.03 |
| 2024-10-01 | -47.09 |
| 2024-09-30 | -48.38 |
| 2024-09-27 | -48.00 |
| 2024-09-26 | -47.63 |
| 2024-09-25 | -47.40 |
| 2024-09-24 | -47.94 |
| 2024-09-23 | -48.69 |
| 2024-09-20 | -49.50 |
| 2024-09-19 | -50.10 |
| 2024-09-18 | -47.98 |
| 2024-09-17 | -48.78 |
| 2024-09-16 | -47.80 |
| 2024-09-13 | -46.79 |
| 2024-09-12 | -43.24 |
| 2024-09-11 | -43.09 |
| 2024-09-10 | -42.27 |
| 2024-09-09 | -41.33 |
| 2024-09-06 | -40.61 |
| 2024-09-05 | -42.31 |
| 2024-09-04 | -42.00 |
| 2024-09-03 | -43.05 |
| 2024-08-30 | -44.84 |
| 2024-08-29 | -45.40 |
| 2024-08-28 | -44.94 |
| 2024-08-27 | -45.48 |
| 2024-08-26 | -45.95 |
| 2024-08-23 | -45.48 |
| 2024-08-22 | -44.14 |
| 2024-08-21 | -44.95 |
| 2024-08-20 | -45.04 |
| 2024-08-19 | -45.96 |
| 2024-08-16 | -46.69 |
| 2024-08-15 | -46.42 |
| 2024-08-14 | -44.33 |
| 2024-08-13 | -46.26 |
| 2024-08-12 | -42.52 |
| 2024-08-09 | -41.60 |
| 2024-08-08 | -42.60 |
| 2024-08-07 | -38.45 |
| 2024-08-06 | -31.01 |
| 2024-08-05 | -29.85 |
| 2024-08-02 | -30.70 |